Erin Resources (ASX:ERI) recently secured an option to wholly-acquire MGC Pharmaceuticals Ltd (MGC), a European medical and cosmetic cannabis company.
MGC has secured key licenses in Slovenia to grow, process and extract, import and export Cannabis Sativa L (Hemp), and related CBD products, into European Union markets
Today Erin has been granted a trading halt pending the execution by MGC of an agreement in the southern hemisphere to complement its existing business.
The halt will remain in place until the opening of trade on Thursday 23rd July 2015, or earlier if an announcement is made to the market.
Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.